Comprehensive Screening of Eight Known Causative Genes in Congenital Hypothyroidism With Gland-in-Situ
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
CONTEXT: Lower TSH screening cutoffs have doubled the ascertainment of congenital hypothyroidism (CH), particularly cases with a eutopically located gland-in-situ (GIS). Although mutations in known dyshormonogenesis genes or TSHR underlie some cases of CH with GIS, systematic screening of these eight genes has not previously been undertaken. OBJECTIVE: Our objective was to evaluate the contribution and molecular spectrum of mutations in eight known causative genes (TG, TPO, DUOX2, DUOXA2, SLC5A5, SLC26A4, IYD, and TSHR) in CH cases with GIS. Patients, Design, and Setting: We screened 49 CH cases with GIS from 34 ethnically diverse families, using next-generation sequencing. Pathogenicity of novel mutations was assessed in silico. PATIENTS, DESIGN, AND SETTING: We screened 49 CH cases with GIS from 34 ethnically diverse families, using next-generation sequencing. Pathogenicity of novel mutations was assessed in silico. RESULTS: Twenty-nine cases harbored likely disease-causing mutations. Monogenic defects (19 cases) most commonly involved TG (12), TPO (four), DUOX2 (two), and TSHR (one). Ten cases harbored triallelic (digenic) mutations: TG and TPO (one); SLC26A4 and TPO (three), and DUOX2 and TG (six cases). Novel variants overall included 15 TG, six TPO, and three DUOX2 mutations. Genetic basis was not ascertained in 20 patients, including 14 familial cases. CONCLUSIONS: The etiology of CH with GIS remains elusive, with only 59% attributable to mutations in TSHR or known dyshormonogenesis-associated genes in a cohort enriched for familial cases. Biallelic TG or TPO mutations most commonly underlie severe CH. Triallelic defects are frequent, mandating future segregation studies in larger kindreds to assess their contribution to variable phenotype. A high proportion (∼41%) of unsolved or ambiguous cases suggests novel genetic etiologies that remain to be elucidated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Strikingly, these variations were found in genes encoding both thyroid transcription factors and proteins involved in TH synthesis, independently of the thyroid phenotype.”
From Congenital Hypothyroidism: A 2020–2021 Consensus Guidelines Update—An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology (2021) · cites this paper as [229]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Such studies strongly suggest that congenital hypothyroidism can frequently be due to the carriage of multiple genetic variants with modest individual effects, but with substantial effects when carried together.[57][58][59]”
From Hypothyroidism (2024) · cites this paper as [59]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Also, recently, NGS studies in cohorts of CH patients screened for mutations in sets of CH genes revealed that a significant proportion of these patients has multiple variations in more than one thyroid-specific gene (89,228,229).”
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“For patients who develop aggressive thyroiditis, this might reflect a better response to treatment with ICIs and an increase in overall survival time.57,59”
From Hypothyroidism (2024) · cites this paper as [59]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
The Phyre2 web portal for protein modeling, prediction and analysis
Kelley, L. A., Mezulis, S., Yates, C. M., Wass, M. N., & Sternberg, M. J. E. (2015) · Nature Protocols · doi:10.1038/nprot.2015.053 · Cited by 9,652 · cited 1×
“The models for TPO and DUOX2 were generated using the phyre2 (Protein Homology/analogy Recognition Engine 2) web portal, which predicts and analyses protein structures based on homology/analogy recognition to solved protein crystal structures (14).”
MethodLéger, J., Olivieri, A., Donaldson, M., Torresani, T., Krude, H., van Vliet, G., Polak, M., Butler, G., & on behalf of ESPE-PES-SLEP-JSPE-APEG-APPES-ISPAE, A. T. C. H. C. C. G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1891 · Cited by 569 · cited 2×
“CH severity is classified according to European Society for Paediatric Endocrinology criteria on the basis of serum fT4 levels; severe, 5, moderate 5 to 10, and mild 10 pmol/liter, respectively (33) and pathogenicity is predicted according to American College of Medical Genetics guidelines (34).”
BackgroundInactivating Mutations in the Gene for Thyroid Oxidase 2 (THOX2) and Congenital Hypothyroidism
Moreno, J. C., Bikker, H., Kempers, M. J. E., van Trotsenburg, A. S. P., Baas, F., de Vijlder, J. J. M., Vulsma, T., & Ris-Stalpers, C. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012752 · Cited by 485
Increase in congenital hypothyroidism in New York State and in the United States
Harris, K. B., & Pass, K. A. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.03.012 · Cited by 270 · cited 1×
“Lower TSH screening cutoffs may be the major driver for this increase in diagnosis, although altered ethnicities of the screened population, increased multiple and premature births, iodine status, and hitherto uncharacterized factors may also contribute (3, 4).”
BackgroundCorbetta, C., Weber, G., Cortinovis, F., Calebiro, D., Passoni, A., Vigone, M. C., Beck‐Peccoz, P., Chiumello, G., & Persani, L. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03568.x · Cited by 247
Genetic causes of congenital hypothyroidism due to dyshormonogenesis
Grasberger, H., & Refetoff, S. (2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32834726a4 · Cited by 213 · cited 1×
“Phenotypic heterogeneity in cases harboring similar causative mutations suggests that mono- and polygenic factors and environmental modulators may also play a role in determining disease severity (7, 8).”
BackgroundBakker, B. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3708 · Cited by 189
Genetics and phenomics of hypothyroidism and goiter due to TPO mutations
Ris‐Stalpers, C., & Bikker, H. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.02.008 · Cited by 150
Rabbiosi, S., Vigone, M. C., Cortinovis, F., Zamproni, I., Fugazzola, L., Persani, L., Corbetta, C., Chiumello, G., & Weber, G. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3174 · Cited by 131
Cited by
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
“Also, recently, NGS studies in cohorts of CH patients screened for mutations in sets of CH genes revealed that a significant proportion of these patients has multiple variations in more than one thyroid-specific gene (89,228,229).”
BackgroundSelf-citationThe ChinaMAP analytics of deep whole genome sequences in 10,588 individuals
The ChinaMAP Consortium, Cao, Y., Li, L., Xu, M., Feng, Z., Sun, X., Lu, J., Xu, Y., Du, P., Wang, T., et al. (2020) · Cell Research · doi:10.1038/s41422-020-0322-9 · Cited by 317
The role of thyroglobulin in thyroid hormonogenesis
Citterio, C. E., Targovnik, H. M., & Arvan, P. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0184-8 · Cited by 216
DIAGNOSIS OF ENDOCRINE DISEASE: Congenital hypothyroidism: update and perspectives
Peters, C., van Trotsenburg, A. S. P., & Schoenmakers, N. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0383 · Cited by 162
Self-citationA frequent oligogenic involvement in congenital hypothyroidism
de Filippis, T., Gelmini, G., Paraboschi, E., Vigone, M. C., Di Frenna, M., Marelli, F., Bonomi, M., Cassio, A., Larizza, D., Moro, M., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx145 · Cited by 145
Wassner, A. J. (2018) · Clinics in Perinatology · doi:10.1016/j.clp.2017.10.004 · Cited by 165
Taylor, P. N., Medici, M. M., Hubalewska-Dydejczyk, A., & Boelaert, K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01614-3 · Cited by 128
“57,59 When managing hypothyroidism from ICI treatment, it is crucial to exclude hypoadrenalism before levothyroxine is initiated, as ICIs can also cause hypoadrenalism, which correction of hypothyroidism would worsen.”
Sun, F., Zhang, J., Yang, C., Gao, G.-Q., Zhu, W., Han, B., Zhang, L., Wan, Y., Ye, X., Ma, Y., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-1017 · Cited by 110
Congenital hypothyroidism: insights into pathogenesis and treatment
Cherella, C. E., & Wassner, A. J. (2017) · International Journal of Pediatric Endocrinology · doi:10.1186/s13633-017-0051-0 · Cited by 106
“On the other hand, in a cohort of mostly European and Middle Eastern patients, variants in TG were much more common (55%) than DUOX2 variants, which were found in only 18% [21].”
BackgroundIodide handling disorders (NIS, TPO, TG, IYD)
Targovnik, H. M., Citterio, C. E., & Rivolta, C. M. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.03.006 · Cited by 106
Pediatric Hypothyroidism: Diagnosis and Treatment
Wassner, A. J. (2017) · Pediatric Drugs · doi:10.1007/s40272-017-0238-0 · Cited by 116
Automated Clinical Exome Reanalysis Reveals Novel Diagnoses
Baker, S. W., Murrell, J. R., Nesbitt, A. I., Pechter, K. B., Balciuniene, J., Zhao, X., Yu, Z., Denenberg, E. H., DeChene, E. T., Wilkens, A., et al. (2018) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2018.07.008 · Cited by 100
Congenital Hypothyroidism: Screening and Management
Rose, S. R., Wassner, A. J., Wintergerst, K. A., Jones, N. Y., Hopkin, R. J., Chuang, J., Smith, J. R., Abell, K. B., LAFRANCHI, S. H., Wintergerst, K. A., et al. (2022) · PEDIATRICS · doi:10.1542/peds.2022-060420 · Cited by 129
Genetics and management of congenital hypothyroidism
Persani, L., Rurale, G., de Filippis, T., Galazzi, E., Muzza, M., & Fugazzola, L. (2018) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2018.05.002 · Cited by 82
Zou, M., Alzahrani, A. S., Al-Odaib, A., Alqahtani, M. A., Babiker, O., Al-Rijjal, R. A., BinEssa, H. A., Kattan, W. E., Al-Enezi, A. F., Al Qarni, A., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02202 · Cited by 78
Kang, H. S., Kumar, D., Liao, G., Lichti-Kaiser, K., Gerrish, K., Liao, X.-H., Refetoff, S., Jothi, R., & Jetten, A. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94417 · Cited by 73
Muzza, M., & Fugazzola, L. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.04.006 · Cited by 76
High frequency of mutations in 'dyshormonogenesis genes' in severe congenital hypothyroidism
Makretskaya, N., Bezlepkina, O. B., Kolodkina, A. A., Kiyaev, A. V., Vasilyev, E., Petrov, V. M., Калиненкова, С. Г., Malievskiy, O. A., Dedov, I. I., & Tiulpakov, A. N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204323 · Cited by 60
Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism
Aycan, Z., Cangul, H., Muzza, M., Bas, V. N., Fugazzola, L., Chatterjee, V. K., Persani, L., & Schoenmakers, N. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00529 · Cited by 60
“In the wider CH context, next-generation sequencing technologies are elucidating a role for oligogenicity in disease pathogenesis (10).”
BackgroundSelf-citationYamaguchi, T., Nakamura, A., Nakayama, K., Hishimura, N., Morikawa, S., Ishizu, K., & Tajima, T. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa308 · Cited by 59
New genetics in congenital hypothyroidism
Stoupa, A., Kariyawasam, D., Muzza, M., de Filippis, T., Fugazzola, L., Polak, M., Persani, L., & Carré, A. (2021) · Endocrine · doi:10.1007/s12020-021-02646-9 · Cited by 59
Peters, C., Nicholas, A. K., Schoenmakers, E., Lyons, G., Langham, S., Serra, E. G., Sebire, N. J., Muzza, M., Fugazzola, L., & Schoenmakers, N. (2019) · Thyroid® · doi:10.1089/thy.2018.0587 · Cited by 57
“, DUOX1), influence of other genetic variants affecting thyroid hormone biosynthesis, or differences in dietary iodide intake (31).”
BackgroundSelf-citationNext-generation sequencing analysis of twelve known causative genes in congenital hypothyroidism
Fan, X., Fu, C., Shen, Y., Li, C., Luo, S., Li, Q., Luo, J., Su, J., Zhang, S., Hu, X., et al. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.02.009 · Cited by 53
Saba, C., Guilmin-Crepon, S., Zénaty, D., Martinerie, L., Paulsen, A., Simon, D., Storey, C., Dos Santos, S., Haignere, J., Mohamed, D., et al. (2018) · Thyroid · doi:10.1089/thy.2018.0154 · Cited by 51
“A role for factors other than known dyshormonogenesis-associated genetic variants or TSH receptor gene variants cannot be excluded, and the possible effects of environmental agents toxic to the fetal and neonatal thyroid gland, such as bisphenols, are currently being investigated (36,37).”
Defects in protein folding in congenital hypothyroidism
Targovnik, H. M., Scheps, K. G., & Rivolta, C. M. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110638 · Cited by 50
DUOX Defects and Their Roles in Congenital Hypothyroidism
Deken, X. D., & Miot, F. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9424-3_37 · Cited by 44
Fetal and Neonatal Thyroid Dysfunction
Léger, J., Delcour, C., & Carel, J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab747 · Cited by 45
Wang, H., Kong, X., Pei, Y., Cui, X., Zhu, Y., He, Z., Wang, Y., Zhang, L., Zhuo, L., Chen, C., et al. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11078 · Cited by 36
Structure and genetic variants of thyroglobulin: Pathophysiological implications
Citterio, C. E., Rivolta, C. M., & Targovnik, H. M. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111227 · Cited by 39
Molecular analysis of thyroglobulin mutations found in patients with goiter and hypothyroidism
Siffo, S., Adrover, E., Citterio, C. E., Miras, M. B., Balbi, V. A., Chiesa, A. E., Weill, J., Sobrero, G. M., González, V. G., Papendieck, P., et al. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.12.009 · Cited by 35
“The same situation 24 M AN US CR IP T AC CE PT ED ACCEPTED MANUSCRIPT 28 has previously been reported by Nicholas et al (2016), where they described several monoallelic TG 1 mutations in individuals with mild CH and a severe hypothyroid patient harboring digenic 2 pathogenic heterozygous variants…”
BackgroundInfluentialStoupa, A., Chehade, G. A. H., Chaabane, R., Kariyawasam, D., Szinnai, G., Hanein, S., Bôle‐Feysot, C., Fourrage, C., Nitschké, P., Thalassinos, C., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.545339 · Cited by 35
“A single study included patients of different ethnicities (7).”
BackgroundInfluentialClinical genetics of defects in thyroid hormone synthesis
Kwak, M. J. (2018) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2018.23.4.169 · Cited by 32
Semantic prioritization of novel causative genomic variants
Boudellioua, I., Razali, R., Kulmanov, M., Hashish, Y., Bajić, V. B., Serra, E. G., Schoenmakers, N. A., Gkoutos, G. V., Schofield, P. N., & Hoehndorf, R. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005500 · Cited by 34
“Of the 43 cases we analyze, 15 individuals with CH were previously subjected to Sanger sequencing of candidate variants, confirming the association with the disease [58].”
BackgroundSelf-citationWang, F., Zang, Y., Li, M., Liu, W., Wang, Y., Yu, X., Li, H., Wang, F., & Liu, S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00237 · Cited by 34
“However, previous studies reported that TG combined with DUOX2 had the most significant variant rate in children with GIS and dyshormonogenesis (19, 43).”
BackgroundResultPetit, I., Édouard, T., Jacques, V., Bournez, M., Cartault, A., Grunenwald, S., & Savagner, F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.657913 · Cited by 27
Genetic analyses in a cohort of Portuguese pediatric patients with congenital hypothyroidism
Silva, R. S., Rosário, M., Grangeia, A., Costa, C., Castro-Correia, C., Alonso, I. D. C. M. P., Leão, M., & Fontoura, M. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2019-0047 · Cited by 29
Persani, L., de Filippis, T., Colombo, C., & Gentilini, D. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0379 · Cited by 28
Boudellioua, I., Kulmanov, M., Schofield, P. N., Gkoutos, G. V., & Hoehndorf, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-32876-3 · Cited by 28
“OligoPVP is freely available at https://github.com/bio-ontology-research-group/phenomenet-vp.”
Stoupa, A., Carré, A., Polak, M., Szinnai, G., & Schoenmakers, N. A. (2025) · European Thyroid Journal · doi:10.1530/etj-24-0348 · Cited by 30
“%) patients involving different combinations of genetic defects (144).”
Self-citationMutation screening of the TSHR gene in 220 Chinese patients with congenital hypothyroidism
Fang, Y., Sun, F., Zhang, R., Zhang, C.-R., Yan, C., Zhou, Z., Zhang, Q.-Y., Li, L., Ying, Y., Zhao, S., et al. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.07.031 · Cited by 22
Genetics of Gland-in-situ or Hypoplastic Congenital Hypothyroidism in Macedonia
Zdraveska, N., Kočova, M., Nicholas, A. K., Anastasovska, V., & Schoenmakers, N. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00413 · Cited by 24
“The incidence of mild GIS CH is increasing, and a previous nextgeneration sequencing (NGS) study in such cases found that biochemically mild CH was less likely to have an identifiable genetic basis, consistent with our low rate of definitively causal mutations (33).”
ResultSelf-citationMutational Spectrum Analysis of Seven Genes Associated with Thyroid Dyshormonogenesis
Chen, X., Kong, X., Zhu, J., Zhang, T., Li, Y., Ding, G., & Wang, H. (2018) · International Journal of Endocrinology · doi:10.1155/2018/8986475 · Cited by 21
“Mutations in DH-associated genes, including TPO, TG, DUOX2, DUOXA2, SLC26A4, SCL5A5, and IYD, have been detected in numerous cases [9, 12, 18].”
BackgroundDUOX2 variants are a frequent cause of congenital primary hypothyroidism in Thai patients
Sorapipatcharoen, K., Tim‐Aroon, T., Mahachoklertwattana, P., Chantratita, W., Iemwimangsa, N., Sensorn, I., Panthan, B., Jiaranai, P., Noojarern, S., Khlairit, P., et al. (2020) · Endocrine Connections · doi:10.1530/ec-20-0411 · Cited by 18
Pio, M. G., Siffo, S., Scheps, K. G., Molina, M. F., Adrover, E., Abelleyro, M. M., Rivolta, C. M., & Targovnik, H. M. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111359 · Cited by 16
Thyroid scintigraphy differentiates subtypes of congenital hypothyroidism
Worth, C., Hird, B., Tetlow, L. J., Wright, N., Patel, L., & Banerjee, I. (2019) · Archives of Disease in Childhood · doi:10.1136/archdischild-2019-317665 · Cited by 15
Genetic and Phenotypic Characteristics of Congenital Hypothyroidism in a Chinese Cohort
Long, W., Guo, F., Yao, R., Wang, Y., Wang, H., Yu, B., & Xue, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.705773 · Cited by 16
Yoon, J. H., Hong, A. R., Kim, H. K., & Kang, H. (2020) · Thyroid · doi:10.1089/thy.2020.0248 · Cited by 13
“TG gene mutations show autosomal recessive inheritance, but a higher frequency of familial TG gene mutations have been reported, compared with other gene mutations, in patients with TD (6,8).”
Genetic testing can change diagnosis and treatment in children with congenital hypothyroidism
Kara, C., Mammadova, J., Abur, Ü., Gümüşkaptan, Ç., Güllü, E. İ., Dağdemir, A., & Aydın, M. (2023) · European Thyroid Journal · doi:10.1530/etj-22-0212 · Cited by 18
Unraveling the Genetics of Congenital Hypothyroidism: Challenges and Opportunities
Wassner, A. J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa454 · Cited by 12
Li, L., Li, X., Wang, X., Han, M., Zhao, D., Wang, F., & Liu, S. (2022) · Endocrine · doi:10.1007/s12020-022-03188-4 · Cited by 12
“00%, 30/375) in our cohort was higher than that in the other seven genes, which was consistent with one previous finding that TG was the most commonly mutated gene in 49 GIS patients [27].”
ResultMcNally, R., Jones, J. H., Shaikh, M. G., Donaldson, M., Blakey, K., & Cheetham, T. D. (2020) · Thyroid · doi:10.1089/thy.2020.0005 · Cited by 12
“We did see evidence to suggest that methodology change was associated with a change in the number of CHT ‘‘cases’’ detected, but this does not preclude a true alteration in incidence of babies with abnormal thyroid gland function (3,4).”
BackgroundAcar, S., Gürsoy, S., Arslan, G., Nalbantoğlu, Ö., Hazan, F., Köprülü, Ö., Özkaya, B., & Özkan, B. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01706-1 · Cited by 13
“However, the contribution of oligogenicity to the clinical phenotype of CH has not been fully elucidated [16, 19, 21, 31, 48].”
BackgroundResultInfluentialMolina, M. F., Papendieck, P., Sobrero, G. M., Balbi, V. A., Belforte, F. S., Bueno‐Martínez, E., Adrover, E., Olcese, M. C., Chiesa, A. E., Miras, M. B., et al. (2022) · Endocrine · doi:10.1007/s12020-022-03054-3 · Cited by 10
Pio, M. G., Molina, M. F., Siffo, S., Chiesa, A. E., Rivolta, C. M., & Targovnik, H. M. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111124 · Cited by 18
Yang, R., Lu, Y., Yang, C., Wu, X., Junqi, F., Zhu, L., Shu, Q., & Jiang, P. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.694683 · Cited by 11
“Whereas thyroid dysgenesis still accounts for more than 69% of primary CH worldwide (Wassner and Brown, 2015; Peters et al., 2018).”
BackgroundLi, L., Jia, C., Li, X., Wang, F., Wang, Y., Chen, Y., Liu, S., & Zhao, D. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.03.015 · Cited by 9
Wu, F., Yang, R., Zhang, H., Zhan, M., Tu, P.-H., Fang, Y., Zhang, C.-X., Song, S., Dong, M., Cui, R.-J., et al. (2023) · Journal of Medical Genetics · doi:10.1136/jmg-2022-108866 · Cited by 8
Molina, M. F., Pio, M. G., Scheps, K. G., Adrover, E., Abelleyro, M. M., Targovnik, H. M., & Rivolta, C. M. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111748 · Cited by 7
Functional Thyroid Organoids—Powerful Stem Cell-Derived Models in Basic and Translational Research
Shankar, M., Boggian, A., Aparicio-Quiñonez, D., Djerbib, S., Rios-Morris, E., Costagliola, S., & Romitti, M. (2025) · Biomolecules · doi:10.3390/biom15050747 · Cited by 8
Levaillant, L., Bouhours‐Nouet, N., Illouz, F., Jager, J. A., Bachelot, A., Barat, P., Baron, S., Bensignor, C., de la Perrière, A. B., Djellas, Y. B., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad119 · Cited by 7
Zhang, T., Shen, Y., Xu, Y., Wu, D., Chen, C., & Yang, R. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117459 · Cited by 8
Cheetham, T. D., & Wood, C. L. (2024) · Clinical Endocrinology · doi:10.1111/cen.15110 · Cited by 11
p.L571P in the linker domain of rat thyroglobulin causes intracellular retention
Citterio, C. E., Siffo, S., Moya, C. M., Pio, M. G., Molina, M. F., Scheps, K. G., Rey, O., Arvan, P., Rivolta, C. M., & Targovnik, H. M. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110719 · Cited by 7
Da, D., Wang, Y., Wang, M., Long, Z. F., Wang, Q., & Liu, J. (2021) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/00469580211067943 · Cited by 8
Fernández‐Cancio, M., Antolín, M., Clemente, M., Campos-Martorell, A., Mogas, E., Baz-Redón, N., Leno-Colorado, J., Comas-Armangué, G., García‐Arumí, E., Soler, L., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1367808 · Cited by 8
“There are several well-known associated genes, including DUOX1, DUOX2, DUOXA1, DUOXA2, SLC26A4, SLC26A7, SLC5A5, TPO, IYD and TG (3, 6, 8 – 10).”
BackgroundZhang, H., Zhang, C.-X., Wu, F., Wu, C., Zhang, F., Liu, Y., Zhang, Y., Song, H., & Zhao, S. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf123 · Cited by 6
Neonatal screening for congenital hypothyroidism: Time to lower the TSH threshold in France
Levaillant, L., Huet, F., Bretones, P., Corne, C., Dupuis, C., Reynaud, R., Somma, C., Barat, P., Corcuff, J., Bouhours‐Nouet, N., et al. (2022) · Archives de Pédiatrie · doi:10.1016/j.arcped.2022.02.001 · Cited by 9
Mortensen, A. H., Fang, Q., Fleming, M. T., Jones, T. J., Daly, A. Z., Johnson, K. R., & Camper, S. A. (2019) · Mammalian Genome · doi:10.1007/s00335-019-09792-6 · Cited by 5
Albader, N., Zou, M., BinEssa, H. A., Abdi, S., Al-Enezi, A. F., Meyer, B. F., Alzahrani, A. S., & Shi, Y. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab737 · Cited by 8
The role of DUOXA2 in the clinical diagnosis of paediatric congenital hypothyroidism
Du, J., Yang, Y., Wei, D., Wu, J.-J., Tian, C., Hu, Q., Bian, H., Chen, C., & Zhai, X. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2440121 · Cited by 6
“The implementation of multigenic screening for CH presents significant opportunities and challenges [70].”
Ahn, J., & Jeong, H. R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094465 · Cited by 4
“To our knowledge, this study represents the first WES-based genetic characterization of permanent CH in Korean children, demonstrating a variant detection rate of 62.5%, which aligns with previously reported rates ranging from 40% to 65% [8–10].”
InfluentialNettore, I. C., Desiderio, S., Nisco, E. D., Cacace, V., Albano, L., Improda, N., Ungaro, P., Salerno, M. C., Colao, A., & Macchia, P. E. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0795-7 · Cited by 4
Double variants in TSHR and DUOX2 in a patient with hypothyroidism: case report
Sasivari, Z., Szinnai, G., Seebauer, B., Konrad, D., & Lang‐Muritano, M. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2019-0051 · Cited by 4
Alcántara‐Ortigoza, M. A., Sánchez-Verdiguel, I., Fernández‐Hernández, L., Enríquez‐Flores, S., González-Núñez, A., Hernández‐Martínez, N. L., Sánchez, C., & Angel, A. G. (2021) · Children · doi:10.3390/children8060457 · Cited by 7
“9%, N = 1/34 families) [51] showing an in situ thyroid gland.”
BackgroundLi, M., Li, X., Wang, F., Ren, Y., Zhang, X., Wang, J., Shen, L., Zhao, D., & ShiguoLiu (2022) · Gene · doi:10.1016/j.gene.2022.146402 · Cited by 4
Genetic Causes of Congenital Hypothyroidism
Schoenmakers, N. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65336-9 · Cited by 4
Self-citationFunctional analysis of PAX8 variants identified in patients with congenital hypothyroidism in situ
Batjargal, K., Tajima, T., Fujita‐Jimbo, E., Yamaguchi, T., Nakamura, A., & Yamagata, T. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2021-0065 · Cited by 5
“Pathogenic variants of patients with CH with GIS were most frequently identified in TG, TPO, DUOX2, and THSR (36).”
BackgroundKurnaz, E., Türkyılmaz, A., Yaralı, O., Donmez, A. S., & Çayır, A. (2024) · Hormone Research in Paediatrics · doi:10.1159/000541898 · Cited by 3
“It has been claimed that this situation may have arisen from a deep, intronic regulatory region or a large gene deletion in the gene that NGS could not detect [25, 32].”
Variant of TSHR is Not a Frequent Cause of Congenital Hypothyroidism in Chinese Han Patients
Xue, P., Yang, Y., Yun, Q., Cui, Y., Yu, B., & Long, W. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s322726 · Cited by 3
Clinical Relevance of Molecular Diagnosis in Patients with Congenital Hypothyroidism
Nicola, J. P. (2017) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000240 · Cited by 5
“Very recently, three independent reports evaluated the clinical usefulness of targeted next-generation sequencing in the diagnosis of congenital hypothyroidism [31-33].”
BackgroundMoncayo, R. (2020) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2020.32 · Cited by 3
Tsai, C., Chang, Y., Chou, Y., Chen, S., Pan, Y., & Tsai, M. (2024) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12871 · Cited by 2
“16,17 These two variants are presented in cis and located in proximity, raising the possibility that they are evolutionarily co-transmitted.”
EL-Ella, S. S. A., Khattab, E. S. A. E. H., beddah, R. K. A., & Barseem, N. F. (2021) · Hormone and Metabolic Research · doi:10.1055/a-1409-5310 · Cited by 1
“detected C51G mutation; 51bp downstream from exon 5 in a non-coding region, through PCR-SSCP [22], whereas another transition substitution at 397 nucleotide sequence (R133W), was not proven to establish direct involvement in different familial thyroid phenotypes [23, 24] and was considered by some as a rare variant, i…”
BackgroundVariation spectra in mild isolated hyperthyrotropinemia: pilot cohort and systematic review
Ricci, V., Masnata, M. E., Gonzalez, M. D. V., Enacán, R. E., Izquierdo, A., Adrover, E., Azcoiti, M. E., Sansó, G., Scaglia, P. A., Rivolta, C. M., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1612450 · Cited by 1
Thyroid Hormone Synthesis Without Thyroglobulin
Young, C., Zhang, X., Kellogg, A. P., Fonseca, T. L., Pena, K., Beyzin, A., Liao, X.-H., Cicatiello, A. G., Zhang, H., Bianco, A. C., et al. (2026) · Thyroid · doi:10.1177/10507256261429120 · Cited by 2
“42,43 However, both monoallelic and biallelic diseases share the phenotype of thyroid cell death.”
Overview of Thyroid Disease in Children and Adolescents
Zwaveling‐Soonawala, N., & van Trotsenburg, A. S. P. (2023) · Endocrinology · doi:10.1007/978-3-030-18901-3_3-1 · Cited by 1
Park, J., Joo, E. Y., Yoo, M. J., Kim, S. J., Jang, W., & Lee, J. E. (2024) · Medicine · doi:10.1097/md.0000000000038976 · Cited by 1
“[8] The prevailing understanding is that most cases of DH caused by genetic variants are hereditary, in an autosomal recessive manner, and manifest as biallelic diseases.”
BackgroundStoupa, A., Carré, A., Polak, M., & Szinnai, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-812531-1.00013-0 · Cited by 1
Thyroglobulin (TG) gene variants in cases with congenital goiter
Cevizoglu, M., Erkal, Ö., & Türkkahraman, D. (2025) · Endocrine Research · doi:10.1080/07435800.2025.2503735 · Cited by 1
“The c.638 + 5 G>A variant has been previously reported 7 to cause a p.P161Ffs5 frameshift mutation through exon skipping, leading to a premature stop codon.”
The Thyroid and Its Regulation by the TSHR: Evolution, Development, and Congenital Defects
Krude, H., & Biebermann, H. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_15 · Cited by 1
Primäre kongenitale Hypothyreose
Baumgartner-Parzer, S. M. (2019) · Journal für Klinische Endokrinologie und Stoffwechsel · doi:10.1007/s41969-019-0068-5 · Cited by 1
Fetal and Neonatal Thyroid Physiology
PAGE, L. C., & Benjamin, R. W. (2018) · Springer eBooks · doi:10.1007/978-3-319-99079-8_5
Semantic Prioritization of Novel Causative Genomic Variants in Mendelian and Oligogenic Diseases
Boudellioua, I. (2019) · King Abdullah University of Science and Technology Repository (King Abdullah University of Science and Technology) · doi:10.25781/kaust-y5g20
“The unexpected involvement of oligogenic and triallelic loss of function/hypomorphic mutations in the genesis of congenital thyroid disease is discussed in [204].”
BackgroundRose, S. R., & Chuang, J. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.04110-6
Faculty Opinions recommendation of Semantic prioritization of novel causative genomic variants.
Smith, B. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727513715.793550373
Kaplan, E. H. A., & Mermer, S. (2022) · Research Square · doi:10.21203/rs.3.rs-1995190/v1
New developments and therapies in pediatric endocrinology
Gevers, E. F., & de Winter, P. (2022) · European Journal of Pediatrics · doi:10.1007/s00431-022-04772-6
Kaplan, E. H. A., & Mermer, S. (2024) · Archives de Pédiatrie · doi:10.1016/j.arcped.2024.03.005 · Cited by 1
Overview of Thyroid Disease in Children and Adolescents
Zwaveling‐Soonawala, N., & van Trotsenburg, A. S. P. (2024) · Endocrinology · doi:10.1007/978-3-030-23709-7_3 · Cited by 1
Boelen, A., van der Spek, A. H., & Fliers, E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00177-1
Metadata
- Authors
- Nicholas, A. K., Serra, E. G., Cangul, H., Alyaarubi, S., Ullah, I., Schoenmakers, E., Deeb, A., Habeb, A. M., Almaghamsi, M., Peters, C., Nathwani, N., Aycan, Z., Saglam, H., Bober, E., Dattani, M., Shenoy, S., Murray, P. G., Babiker, A., Willemsen, R., Thankamony, A., Lyons, G., Irwin, R., Padidela, R., Tharian, K., Davies, J. H., Puthi, V., Park, S.-M., Massoud, A. F., Gregory, J. W., Albanese, A., Pease-Gevers, E., Martin, H., Brugger, K., Maher, E. R., Chatterjee, V. K. K., Anderson, C. A., & Schoenmakers, N.
- Affiliations
- University of Cambridge (GB)
- St George's Hospital (GB)
- Corresponding author
- Schoenmakers, Nadia
- ORCID
- Nicholas, Adeline K.
- Serra, Eva G.
- Schoenmakers, Erik
- Deeb, Asma
- Habeb, Abdelhadi M.
- Peters, Catherine
- Aycan, Zehra
- Dattani, Mehul
- Murray, Philip G.
- Babiker, Amir
- Willemsen, Ruben
- Thankamony, Ajay
- Padidela, Raja
- Davies, Justin H.
- Park, Soo-Mi
- Massoud, Ahmed F.
- Gregory, John W.
- Albanese, Assunta
- Martin, Howard
- Maher, Eamonn R.
- Anderson, Carl A.
- Schoenmakers, Nadia
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-12
- Volume
- 101
- Issue
- 12
- Pages
- 4521-4531
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC5155683
- OpenAlex
- W2511437298
- Cited by
- 112
- References
- 35
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 11 · 2023: 5 · 2022: 9 · 2021: 16 · 2020: 13 · 2019: 12 · 2018: 15 · 2017: 12
- FWCI
- 13.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, cc-by)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- Research Explorer (The University of Manchester) (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Bursa Uludag University - AVESIS (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Apollo (cc-by)
- Funders
- Wellcome Trust (095564/Z/11/Z, UK10K, 100585/Z/12/Z, WT091310, 098051)
- National Institute for Health and Care Research (NF-SI-0514-10176, CL-2012-06-005)
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Surgery › Head and Neck Anomalies
- Keywords
- congenital hypothyroidism, dyshormonogenesis, thyroglobulin, thyroid peroxidase, DUOX2, DUOXA2, SLC26A4, sodium iodide symporter, iodide transporter, TSH receptor, novel mutations, familial hypothyroidism, genetic etiology
- MeSH terms
- Autoantigens, Congenital Hypothyroidism, Humans, Iodide Peroxidase, Mutation, Pedigree, Phenotype, Receptors, Thyrotropin, Thyroglobulin, Iron-Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.